atenolol has been researched along with 2019 Novel Coronavirus Disease in 1 studies
Atenolol: A cardioselective beta-1 adrenergic blocker possessing properties and potency similar to PROPRANOLOL, but without a negative inotropic effect.
atenolol : An ethanolamine compound having a (4-carbamoylmethylphenoxy)methyl group at the 1-position and an N-isopropyl substituent.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ulvi, A | 1 |
| Aydın, S | 1 |
| Aydın, ME | 1 |
1 other study available for atenolol and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Fate of selected pharmaceuticals in hospital and municipal wastewater effluent: occurrence, removal, and environmental risk assessment.
Topics: Atenolol; Carbamazepine; COVID-19; Environmental Monitoring; Hospitals; Humans; Lipids; Pandemics; P | 2022 |